H.C. Wainwright raised the firm’s price target on Sol-Gel Technologies (SLGL) to $110 from $50 and keeps a Buy rating on the shares. The firm now anticipates that SGT-610 may generate peak annual sales approaching $640M by the mid-2030s.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLGL:
- Sol-Gel: SGT-610 as Core Value Driver Underpins $50 Target and Buy Rating Despite Pipeline Setbacks
- Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results
- Sol-Gel decides not to advance SGT-210 development in Darier disease
- One new option listing and fifteen option delistings on November 24th
- Sol-Gel Technologies Announces Q3 2025 Financial Results and Strategic Developments